Cargando…

Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model

INTRODUCTION: The coronavirus disease 2019 (COVID-19) pandemic continues to cause significant morbidity and mortality worldwide. Since a large portion of the world’s population is currently unvaccinated or incompletely vaccinated and has limited access to approved treatments against COVID-19, there...

Descripción completa

Detalles Bibliográficos
Autores principales:	Péricat, D., Leon-Icaza, S. A., Sánchez-Rico, M., Mühle, C., Zoicas, I., Schumacher, F., Planès, R., Mazars, R., Gros, G., Carpinteiro, A., Becker, K. A., Izopet, J., Strub-Wourgaft, N., Sjö, P., Neyrolles, O., Kleuser, B., Limosin, F., Gulbins, E., Kornhuber, J., Meunier, E., Hoertel, N., Cougoule, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595818/ http://dx.doi.org/10.1192/j.eurpsy.2023.318

Ejemplares similares

Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model
por: Péricat, David, et al.
Publicado: (2022)

Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19
por: Hoertel, N., et al.
Publicado: (2023)

Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19
por: Hoertel, Nicolas, et al.
Publicado: (2022)

Comorbid medical conditions are a key factor to understand the relationship between psychiatric disorders and COVID-19-related mortality: Results from 49,089 COVID-19 inpatients
por: Hoertel, Nicolas, et al.
Publicado: (2021)

Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms
por: Hoertel, Nicolas, et al.
Publicado: (2021)

Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study
por: Hoertel, Nicolas, et al.
Publicado: (2023)

Development of Comorbid Depression after Social Fear Conditioning in Mice and Its Effects on Brain Sphingolipid Metabolism
por: Zoicas, Iulia, et al.
Publicado: (2023)

Association between FIASMA psychotropic medications and reduced risk of intubation or death in individuals with psychiatric disorders hospitalized for severe COVID-19: an observational multicenter study
por: Hoertel, Nicolas, et al.
Publicado: (2022)

Association between benzodiazepine receptor agonist use and mortality in patients hospitalised for COVID-19: a multicentre observational study
por: Hoertel, N., et al.
Publicado: (2022)

Anxiety and Depression Are Related to Higher Activity of Sphingolipid Metabolizing Enzymes in the Rat Brain
por: Zoicas, Iulia, et al.
Publicado: (2020)

Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID‐19: An Observational Multicenter Study
por: Hoertel, Nicolas, et al.
Publicado: (2021)

The Forebrain-Specific Overexpression of Acid Sphingomyelinase Induces Depressive-Like Symptoms in Mice
por: Zoicas, Iulia, et al.
Publicado: (2020)

Risk of Death in Individuals Hospitalized for COVID-19 With and Without Psychiatric Disorders: An Observational Multicenter Study in France
por: Hoertel, Nicolas, et al.
Publicado: (2022)

The acid sphingomyelinase/ceramide system in COVID-19
por: Kornhuber, Johannes, et al.
Publicado: (2021)

Role of Acid Sphingomyelinase in the Regulation of Social Behavior and Memory
por: Zoicas, Iulia, et al.
Publicado: (2016)

Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells
por: Carpinteiro, Alexander, et al.
Publicado: (2021)

EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial barrier disruption
por: Pinilla, Miriam, et al.
Publicado: (2023)

Mortality in older adults with severe mental illness: the role of metabolic syndrome and its components
por: Abou Kassm, S., et al.
Publicado: (2023)

Ceramide levels in blood plasma correlate with major depressive disorder severity and its neutralization abrogates depressive behavior in mice
por: Schumacher, Fabian, et al.
Publicado: (2022)

Peripheral Acid Sphingomyelinase Activity Is Associated with Biomarkers and Phenotypes of Alcohol Use and Dependence in Patients and Healthy Controls
por: Mühle, Christiane, et al.
Publicado: (2018)

Ex vivo assay to evaluate the efficacy of drugs targeting sphingolipids in preventing SARS-CoV-2 infection of nasal epithelial cells
por: Becker, Katrin Anne, et al.
Publicado: (2021)

Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease
por: Hoertel, Nicolas, et al.
Publicado: (2022)

Stress induces major depressive disorder by a neutral sphingomyelinase 2-mediated accumulation of ceramide-enriched exosomes in the blood plasma
por: Schumacher, Fabian, et al.
Publicado: (2022)

mRNA Expression of SMPD1 Encoding Acid Sphingomyelinase Decreases upon Antidepressant Treatment
por: Rhein, Cosima, et al.
Publicado: (2021)

Neuropeptide Y prolongs non-social memory and differentially affects acquisition, consolidation, and retrieval of non-social and social memory in male mice
por: Kornhuber, Johannes, et al.
Publicado: (2017)

The Role of Metabotropic Glutamate Receptors in Social Behavior in Rodents
por: Zoicas, Iulia, et al.
Publicado: (2019)

Social Fear Memory Requires Two Stages of Protein Synthesis in Mice
por: Kornhuber, Johannes, et al.
Publicado: (2020)

Neuropeptide Y as Alternative Pharmacotherapy for Antidepressant-Resistant Social Fear
por: Kornhuber, Johannes, et al.
Publicado: (2020)

The Role of the N-Methyl-D-Aspartate Receptors in Social Behavior in Rodents
por: Zoicas, Iulia, et al.
Publicado: (2019)

Neuropeptide Y reduces expression of social fear via simultaneous activation of Y1 and Y2 receptors
por: Kornhuber, Johannes, et al.
Publicado: (2019)

Brain Region-Dependent Effects of Neuropeptide Y on Conditioned Social Fear and Anxiety-Like Behavior in Male Mice
por: Kornhuber, Johannes, et al.
Publicado: (2021)

Neuropeptide Y Reduces Social Fear in Male Mice: Involvement of Y1 and Y2 Receptors in the Dorsolateral Septum and Central Amygdala
por: Kornhuber, Johannes, et al.
Publicado: (2021)

Acid Sphingomyelinase Is a Modulator of Contextual Fear
por: Zoicas, Iulia, et al.
Publicado: (2022)

Caspase-1-driven neutrophil pyroptosis and its role in host susceptibility to Pseudomonas aeruginosa
por: Santoni, Karin, et al.
Publicado: (2022)

Comorbidity patterns and mortality among hospitalized patients with psychiatric disorders and COVID-19
por: Sánchez-Rico, Marina, et al.
Publicado: (2023)

Long-term care utilization within older adults with schizophrenia: Associated factors in a multicenter study
por: Pierre, L., et al.
Publicado: (2023)

FLUOXETINE AND PARESTHESIAS
por: Pfizer, N., et al.
Publicado: (2001)

Secretory Acid Sphingomyelinase in the Serum of Medicated Patients Predicts the Prospective Course of Depression
por: Mühle, Christiane, et al.
Publicado: (2019)

Sphingosine as a New Antifungal Agent against Candida and Aspergillus spp.
por: Hashemi Arani, Fahimeh, et al.
Publicado: (2022)

Author Correction: A stochastic agent-based model of the SARS-CoV-2 epidemic in France
por: Hoertel, Nicolas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5rvkov1ojs8tanq7os64fiqms8